Adoptive transfer of Treg populations into APP/PS1/tau triple transgenic AD mice reduces the Aβ burden, microglial activation, and pro-inflammatory cytokine levels (Baek et al., 2016). This evidence concerns the gene MAPT and Alzheimer disease.